{"product_id":"biolionaire-scientist-volume-1-mohammad-arghavani-9798274457866","title":"BioLionaire Scientist-Volume 1: ANTIBODY EMPIRE: How Curious Scientists Built a $200B Biotherapeutics Revolution","description":"\u003cp\u003e\u003ci\u003eAntibody Empire\u003c\/i\u003e opens the BioLionaire Scientist series with a deep exploration of how monoclonal antibodies evolved from academic immunology experiments into one of the most powerful therapeutic platforms in modern medicine.\u003c\/p\u003e\u003cp\u003eThis volume examines the scientific breakthroughs, engineering refinements, clinical turning points, and strategic decisions that transformed antibodies into a multi-hundred-billion-dollar global industry. Rather than presenting a simplified success narrative, the book analyzes the real mechanisms behind platform creation - from hybridoma technology and recombinant engineering to immune checkpoint modulation and translational funding pathways.\u003c\/p\u003e\u003cp\u003eThrough detailed scientific discussion and strategic analysis, the book demonstrates how curiosity-driven laboratory discoveries matured into dominant oncology and autoimmune therapeutics. It connects molecular immunology to manufacturing scale, patent protection, regulatory positioning, and capital formation.\u003c\/p\u003e\u003cp\u003eThis is a scientifically rigorous guide for researchers who want to understand not only how antibodies work - but how therapeutic empires are built.\u003c\/p\u003e\u003cb\u003eWho This Book Is For\u003c\/b\u003e\u003cp\u003eThis volume is written for graduate students, postdoctoral researchers, clinician-scientists, biotechnology founders, translational investigators, and professionals seeking a deeper understanding of biologics strategy. It is equally suited for academic libraries, research institutions, and innovation-focused biotech teams.\u003c\/p\u003e\u003cb\u003eWhat This Book Covers\u003c\/b\u003e\u003cp\u003eThe book explores the biological foundations of antibody specificity, immune recognition, and monoclonal antibody development. It then moves into the engineering era - including humanization, Fc optimization, bispecific formats, and antibody-drug conjugates.\u003c\/p\u003e\u003cp\u003eMajor oncology case studies such as CD20 targeting, HER2-directed therapy, CTLA-4 blockade, and PD-1 immune checkpoint modulation are analyzed not only for their biological significance, but for their strategic and commercial implications.\u003c\/p\u003e\u003cp\u003eLater chapters address manufacturing scalability, quality control systems, patent architecture, translational grant funding, SBIR mechanisms, startup formation, and biotech valuation frameworks.\u003c\/p\u003e\u003cp\u003eThe volume closes by synthesizing scientific innovation with execution strategy - outlining the BioLionaire blueprint for platform dominance.\u003c\/p\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cp\u003e\u003cb\u003ePart I - The Science of Antibodies\u003c\/b\u003e\u003cbr\u003eChapter 1 - Antibody Basics\u003cbr\u003eChapter 2 - Monoclonal Antibodies\u003cbr\u003eChapter 3 - Engineering the Future\u003c\/p\u003e\u003cp\u003e\u003cb\u003ePart II - From Bench to Blockbuster\u003c\/b\u003e\u003cbr\u003eChapter 4 - The First Billion-Dollar Antibodies\u003cbr\u003eChapter 5 - The Immuno-Oncology Era\u003cbr\u003eChapter 6 - Antibodies Beyond Cancer\u003c\/p\u003e\u003cp\u003e\u003cb\u003ePart III - The Business of Antibodies\u003c\/b\u003e\u003cbr\u003eChapter 7 - Anatomy of a Blockbuster Deal\u003cbr\u003eChapter 8 - The Biotech Playbook\u003cbr\u003eChapter 9 - Manufacturing and the Money Pipeline\u003c\/p\u003e\u003cp\u003e\u003cb\u003ePart IV - Future Antibody Empire\u003c\/b\u003e\u003cbr\u003eChapter 10 - Next-Gen Antibodies\u003cbr\u003eChapter 11 - Deep learning for antibody design\u003cbr\u003eChapter 12 - Building Your Own Antibody Path\u003cbr\u003eChapter 13 - Approaching Funding Bodies\u003c\/p\u003e\u003cp\u003e\u003cb\u003eAppendices\u003c\/b\u003e\u003cbr\u003eAppendix A - Antibodies Discussed in Antibody Empire\u003cbr\u003eAppendix B - Sample K99\/R00 NIH Proposal\u003cbr\u003eAppendix C - Common Antibody CROs\u003cbr\u003eAppendix D - How to Choose a CRO\u003c\/p\u003e\u003cp\u003eGlossary\u003cbr\u003eIndex\u003cbr\u003eCompanies \u0026amp; Platforms Discussed in this Volume\u003cbr\u003eEssential Reading\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eAuthor:\u003c\/b\u003e Mohammad Arghavani,Shanli Salahi,Parham Jabbarzadeh Kaboli\u003cbr\u003e\u003cb\u003eISBN-13:\u003c\/b\u003e 9798274457866\u003cbr\u003e\u003cb\u003ePublisher:\u003c\/b\u003e Independently Published\u003cbr\u003e\u003cb\u003eLanguage:\u003c\/b\u003e English\u003cbr\u003e\u003cb\u003ePublished:\u003c\/b\u003e 03\/02\/2026\u003cbr\u003e\u003cb\u003ePages:\u003c\/b\u003e 310\u003cbr\u003e\u003cb\u003eFormat:\u003c\/b\u003e Paperback\u003cbr\u003e\u003cb\u003eWeight:\u003c\/b\u003e 1.19lbs\u003cbr\u003e\u003cb\u003eSize:\u003c\/b\u003e 10.00h x 7.00w x 0.65d","brand":"Mohammad Arghavani","offers":[{"title":"Paperback","offer_id":48443198374143,"sku":"9798274457866","price":23.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/2982\/9887\/files\/img_ae64b66f-62a1-4f50-b552-950747b0118c.jpg?v=1777202510","url":"https:\/\/www.whiterainbookhouse.com\/products\/biolionaire-scientist-volume-1-mohammad-arghavani-9798274457866","provider":"WR Book House","version":"1.0","type":"link"}